Christopher A. Bleck, Chief Commercial Officer at OvaScience, Inc. (OVAS), bought 2,000 shares at $11.15 ($22K) on 2013-09-11, disclosed to the SEC on 2013-09-12.
Open-market purchase of $22k OVAS by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.